Equities

Hemispherx Biopharma Inc

Hemispherx Biopharma Inc

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (USD)0.4643
  • Today's Change-0.0000000000000001 / 0.00%
  • Shares traded191.06k
  • 1 Year change-4.27%
  • Beta-0.4428
Data delayed at least 15 minutes, as of Feb 22 2018 01:00 GMT.
More ▼

Events & Activity

  • HEB:ASQ price moved over +2.22% to 0.4566
  • HEB:ASQ price rises above 15-day moving average to 0.4605 at 10:33 GMT

Key statistics

On Thursday, Hemispherx Biopharma Inc (HEB:ASQ) closed at 0.4643, 54.77% above the 52 week low of 0.300 set on Nov 02, 2017.
52-week range
Today
0.300Nov 02 20170.8357Apr 25 2017
Markit short selling activity
Low
Med
High
Open0.4405
High0.47
Low0.4405
Bid--
Offer--
Previous close0.4643
Average volume284.57k
Shares outstanding31.87m
Free float30.47m
P/E (TTM)--
Market cap14.80m USD
EPS (TTM)-0.2818
USD
Data delayed at least 15 minutes, as of Feb 22 2018 01:00 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.